Cargando…
The long and sinuous road to phage-based therapy of Clostridioides difficile infections
With the antibiotic crisis and the rise in antimicrobial resistance worldwide, new therapeutic alternatives are urgently needed. Phage therapy represents one of the most promising alternatives but for some pathogens, such as Clostridioides difficile, important challenges are being faced. The perspec...
Autores principales: | Umansky, Andrew A., Fortier, Louis Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481535/ https://www.ncbi.nlm.nih.gov/pubmed/37680620 http://dx.doi.org/10.3389/fmed.2023.1259427 |
Ejemplares similares
-
From the bench to the market: the long, sinuous and rocky road
por: Buzalaf, Marília Afonso Rabelo
Publicado: (2016) -
Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022) -
Clostridioides difficile S-Layer Protein A (SlpA) Serves as a General Phage Receptor
por: Royer, Alexia L. M., et al.
Publicado: (2023) -
Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023) -
Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
por: Fortier, Louis-Charles
Publicado: (2018)